Showing results (241-250 of 511) with videos related to
Sort By:
Pageof 52
Nuclear Medicine Communications|July 14, 2017
Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsiMichael A Gorin, Wael Marashdeh, Ashley E Ross, et al.Neoplasia (New York, N.Y.)|July 17, 2004
Detection and isolation of circulating tumor cells in urologic cancers: a reviewRobert D Loberg, Yaron Fridman, Brian A Pienta, et al.Clinical Nuclear Medicine|August 15, 2017
An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CTSteven P Rowe, Michael A Gorin, Linda C Chu, et al.Convergent Science Physical Oncology|March 13, 2018
Epithelial and mesenchymal prostate cancer cell population dynamics on a complex drug landscapeKe-Chih Lin, Gonzalo Torga, Amy Wu, et al.Journal of Cellular Biochemistry|August 28, 2014
The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptorSteven M Mooney, Princy Parsana, James R Hernandez, et al.Clinical & Experimental Metastasis|March 29, 2002
The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokinesCarlton R Cooper, Jasmine K Bhatia, Heather J Muenchen, et al.Cancer|May 13, 2006
Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostateNiklas J Mackler, Rodney L Dunn, Beth Hellerstedt, et al.Neoplasia (New York, N.Y.)|August 23, 2002
Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinomaKenneth L van Golen, LiWei Bao, George J Brewer, et al.Clinical & Experimental Metastasis|October 4, 2003
Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endotheliumOlga V Glinskii, Virginia H Huxley, James R Turk, et al.Expert Review of Anticancer Therapy|May 23, 2022
Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancerAndrew F Voter, Rudolf A Werner, Kenneth J Pienta, et al.Pageof 52